180 related articles for article (PubMed ID: 22673826)
1. Validity of self-reported osteoporosis in mid-age and older women.
Peeters GM; Tett SE; Dobson AJ; Mishra GD
Osteoporos Int; 2013 Mar; 24(3):917-27. PubMed ID: 22673826
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis quality indicators using healthcare utilization data.
Cadarette SM; Jaglal SB; Raman-Wilms L; Beaton DE; Paterson JM
Osteoporos Int; 2011 May; 22(5):1335-42. PubMed ID: 20577872
[TBL] [Abstract][Full Text] [Related]
3. Validation of a case definition for osteoporosis disease surveillance.
Leslie WD; Lix LM; Yogendran MS
Osteoporos Int; 2011 Jan; 22(1):37-46. PubMed ID: 20458577
[TBL] [Abstract][Full Text] [Related]
4. Validity of Self-Reported Medication Use Compared With Pharmacy Records in a Cohort of Older Women: Findings From the Women's Health Initiative.
Drieling RL; LaCroix AZ; Beresford SA; Boudreau DM; Kooperberg C; Heckbert SR
Am J Epidemiol; 2016 Aug; 184(3):233-8. PubMed ID: 27402774
[TBL] [Abstract][Full Text] [Related]
5. Extensive undertreatment of osteoporosis in older Swedish women.
Lorentzon M; Nilsson AG; Johansson H; Kanis JA; Mellström D; Sundh D
Osteoporos Int; 2019 Jun; 30(6):1297-1305. PubMed ID: 30805678
[TBL] [Abstract][Full Text] [Related]
6. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
[TBL] [Abstract][Full Text] [Related]
7. Effect of the women's health initiative on prescription anti-osteoporosis medication utilization.
Farley JF; Blalock SJ; Cline RR
Osteoporos Int; 2008 Nov; 19(11):1603-12. PubMed ID: 18373048
[TBL] [Abstract][Full Text] [Related]
8. Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.
Si L; Winzenberg TM; Jiang Q; Palmer AJ
Osteoporos Int; 2015 May; 26(5):1477-89. PubMed ID: 25567776
[TBL] [Abstract][Full Text] [Related]
9. Prevalent vertebral fractures predict subsequent radiographic vertebral fractures in postmenopausal Korean women receiving antiresorptive agent.
Kim SH; Choi HS; Rhee Y; Kim KJ; Lim SK
Osteoporos Int; 2011 Mar; 22(3):781-7. PubMed ID: 20533028
[TBL] [Abstract][Full Text] [Related]
10. Self-perception of fracture risk: what can it tell us?
Litwic AE; Compston JE; Wyman A; Siris ES; Gehlbach SH; Adachi JD; Chapurlat R; Díez-Pérez A; LaCroix AZ; Nieves JW; Netelenbos JC; Pfeilschifter J; Rossini M; Roux C; Saag KG; Silverman S; Watts NB; Greenspan SL; March L; Gregson CL; Cooper C; Dennison EM;
Osteoporos Int; 2017 Dec; 28(12):3495-3500. PubMed ID: 28861636
[TBL] [Abstract][Full Text] [Related]
11. Poor agreement between self-reported diagnosis and bone mineral density results in the identification of osteoporosis.
Stuart AL; Williams LJ; Brennan SL; Kotowicz MA; Pasco JA
J Clin Densitom; 2015; 18(1):13-6. PubMed ID: 24912958
[TBL] [Abstract][Full Text] [Related]
12. Validity of self-reported cancer: Comparison between self-report versus cancer registry records in the Geelong Osteoporosis Study.
Cowdery SP; Stuart AL; Pasco JA; Berk M; Campbell D; Williams LJ
Cancer Epidemiol; 2020 Oct; 68():101790. PubMed ID: 32745997
[TBL] [Abstract][Full Text] [Related]
13. Association between incident and baseline vertebral fractures in European women: vertebral fracture assessment in the Osteoporosis and Ultrasound Study (OPUS).
Ferrar L; Roux C; Felsenberg D; Glüer CC; Eastell R
Osteoporos Int; 2012 Jan; 23(1):59-65. PubMed ID: 21732219
[TBL] [Abstract][Full Text] [Related]
14. Impact of medication adherence on health care utilization and productivity: self-reported data from a cohort of postmenopausal women on osteoporosis therapy.
Wade SW; Satram-Hoang S; Nadkar A; Macarios D; Tosteson AN
Clin Ther; 2011 Dec; 33(12):2006-15. PubMed ID: 22099387
[TBL] [Abstract][Full Text] [Related]
15. Minimal error in self-report of having had DXA, but self-report of its results was poor.
Cadarette SM; Beaton DE; Gignac MA; Jaglal SB; Dickson L; Hawker GA
J Clin Epidemiol; 2007 Dec; 60(12):1306-11. PubMed ID: 17998086
[TBL] [Abstract][Full Text] [Related]
16. Design of the POSSIBLE UStrade mark Study: postmenopausal women's compliance and persistence with osteoporosis medications.
Barrett-Connor E; Ensrud K; Tosteson AN; Varon SF; Anthony M; Daizadeh N; Wade S
Osteoporos Int; 2009 Mar; 20(3):463-72. PubMed ID: 18607669
[TBL] [Abstract][Full Text] [Related]
17. Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study.
Kanterewicz E; Puigoriol E; Rodríguez Cros JR; Peris P
Osteoporos Int; 2019 Oct; 30(10):2141-2149. PubMed ID: 31123788
[TBL] [Abstract][Full Text] [Related]
18. The burden and undertreatment of fragility fractures among senior women.
Rodrigues AM; Eusébio M; Santos MJ; Gouveia N; Tavares V; Coelho PS; Mendes JM; Branco JC; Canhão H
Arch Osteoporos; 2018 Mar; 13(1):22. PubMed ID: 29516239
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study.
Roux C; Cooper C; Díez-Pérez A; Martinez L; Ortolani S; Gitlin M; Möller G; Shepherd S; Freemantle N
Osteoporos Int; 2011 Apr; 22(4):1227-36. PubMed ID: 20628731
[TBL] [Abstract][Full Text] [Related]
20. Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™.
Barrett-Connor E; Wade SW; Downs RW; Ganiats T; Hochberg M; Recker RR; Stolshek BS
Osteoporos Int; 2015 Aug; 26(8):2175-84. PubMed ID: 25876880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
